Autoimmune hemolytic anemia associated with infliximab infusion in ulcerative colitis

被引：10

作者：

Mir, Fazia A. ^{[1
]}

Al Juboori, Alhareth ^{[1
]}

Bragg, Jack D. ^{[1
]}

Tahan, Veysel ^{[1
]}

机构：

[1] Missouri Univ, Dept Gastroenterol & Hepatol, Columbia, MO USA

来源：

NORTHERN CLINICS OF ISTANBUL | 2018年 / 5卷 / 01期

关键词：

Autoimmune hemolytic anemia; inflammatory bowel disease; infliximab; ulcerative colitis;

D O I：

10.14744/nci.2017.77045

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Infliximab is a monoclonal antibody that antagonizes the activity of tumor necrosis factor alpha to induce and maintain remission in patients with inflammatory bowel disease. Adverse effects associated with Infliximab infusions include infusion reactions, risk of infections, development of hematological malignancies, and pancytopenia. Autoimmune hemolytic anemia has rarely been reported in ulcerative colitis. Herein we report a case of drug-induced hemolytic anemia after infliximab infusion for treating ulcerative colitis.

引用

页码：64 / 66

页数：3

共 10 条

[1]

Aronson J.K., 2009, MEYLERS SIDE EFFECTS

[2]

Chaudhary R K, 2014, Asian J Transfus Sci, V8, P5, DOI 10.4103/0973-6247.126681

[3] Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study [J].

Fidder, H. ;

Schnitzler, F. ;

Ferrante, M. ;

Noman, M. ;

Katsanos, K. ;

Segaert, S. ;

Henckaerts, L. ;

Van Assche, G. ;

Vermeire, S. ;

Rutgeerts, P. .

GUT, 2009, 58 (04) :501-508

[4] Autoimmune hemolytic anemia [J].

Gehrs, BC ;

Friedberg, RC .

AMERICAN JOURNAL OF HEMATOLOGY, 2002, 69 (04) :258-271

[5]

Carnerero EL, 2014, REV ESP ENFERM DIG, V106, P295

[6] Autoimmune Hemolytic Anemia Associated With Ulcerative Colitis: Response to Infliximab [J].

Leo Carnerero, Eduardo ;

Aoufi, Sami ;

Montero Cuadrado, Isabel ;

Herrera Martin, Pablo ;

Herrera Justiniano, Jose Manuel .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (09) :2370-2371

[7] Autoimmune Hemolytic Anemia Associated With Ulcerative Colitis: The Most Important Step Is to Induce Complete Remission [J].

Molnar, Tamas ;

Farkas, Klaudia ;

Szepes, Zoltan ;

Nagy, Ferenc ;

Wittmann, Tibor .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (05) :1203-1204

[8] Infliximab for induction and maintenance therapy for ulcerative colitis [J].

Rutgeerts, P ;

Sandborn, WJ ;

Feagan, BG ;

Reinisch, W ;

Olson, A ;

Johanns, J ;

Travers, S ;

Rachmilewitz, D ;

Hanauer, SB ;

Lichtenstein, GR ;

de Villiers, WJS ;

Present, D ;

Sands, BE ;

Colombel, JF .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (23) :2462-2476

[9] Autoimmunity associated with anti-tumor necrosis factor α treatment in Crohn's disease:: A prospective cohort study [J].

Vermeire, S ;

Noman, M ;

Van Assche, G ;

Baert, F ;

Van Steen, K ;

Esters, N ;

Joossens, S ;

Bossuyt, X ;

Rutgeerts, P .

GASTROENTEROLOGY, 2003, 125 (01) :32-39

[10]

Vermeire S, 2002, AM J GASTROENTEROL, V97, P2357

← 1 →